BamSEC and AlphaSense Join Forces
Learn More

Traws Pharma Inc.

NASDAQ: TRAW    
Share price (12/24/24): $11.61    
Market cap (12/24/24): $35.1 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.2
from 8-K 1 page Certificate of Amendment to Tenth Amended and Restated Certificate of Incorporation of Traws Pharma, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to Tenth Amended and Restated Certificate of Incorporation of Traws Pharma, Inc
12/34/56
EX-3.1
from 8-K 2 pages Amendment No. 1 to the Amended and Restated Bylaws of Traws Pharma, Inc
12/34/56
EX-3.2
from 8-K 2 pages Certificate of Amendment to Tenth Amended and Restated Certificate of Incorporation of Onconova Therapeutics, Inc
12/34/56
EX-3.2
from DEFA14A 2 pages Certificate of Amendment to Tenth Amended and Restated Certificate of Incorporation of Onconova Therapeutics, Inc
12/34/56
EX-3.1
from DEFA14A 15 pages Onconova Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series C Non-Voting Convertible Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-K 15 pages Onconova Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series C Non-Voting Convertible Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.2
from 8-K 1 page Certificate of Amendment to Tenth Amended and Restated Certificate of Incorporation of Onconova Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to Tenth Amended and Restated Certificate of Incorporation of Onconova Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to Tenth Amended and Restated Certificate of Incorporation of Onconova Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to Tenth Amended and Restated Certificate of Incorporation of Onconova Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 12 pages Onconova Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.6
from S-1/A 12 pages Onconova Therapeutics, Inc. Form of Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.6
from S-1/A 12 pages Onconova Therapeutics, Inc. Form of Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to Tenth Amended and Restated Certificate of Incorporation of Onconova Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 12 pages Terms of Series a Convertible Preferred Stock
12/34/56
EX-3.4
from S-1/A 12 pages Terms of Series a Convertible Preferred Stock
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to Tenth Amended and Restated Certificate of Incorporation of Onconova Therapeutics, Inc
12/34/56
EX-3.2
from 8-K 16 pages Onconova Therapeutics, Inc. Amended and Restated Bylaws Section 1—offices
12/34/56
EX-3.1
from 8-K 5 pages Tenth Amended and Restated Certificate of Incorporation of Onconova Therapeutics, Inc
12/34/56